Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

95
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
95
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

146
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
146
Three-Compartment Open Model01:06

Three-Compartment Open Model

680
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
680
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

90
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
90
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

97
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
97
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

86
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Patient Safety: Introducing Barcode Medication Administration (BCMA) Technology at a Cancer Center in Jordan.

Computers, informatics, nursing : CIN·2026
Same author

The Impact of Pharmacist-Led Antimicrobial Stewardship Review of Cultures in the Ambulatory Setting at a Comprehensive Cancer Center.

Hospital pharmacy·2023
Same author

Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.

Pharmacology research & perspectives·2022
Same author

Augmented renal clearance in critically ill patients with cancer (ARCCAN Study): A prospective observational study evaluating prevalence and risk factors.

Pharmacology research & perspectives·2021
Same author

Intensive Care Unit readmissions- separate entity or a disease continuum.

Journal of critical care·2019
Same author

ICU readmission of patients with cancer: Incidence, risk factors and mortality.

Journal of critical care·2019

Related Experiment Video

Updated: Nov 29, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.1K

Establishing a Structured Pharmacy Training Program in Sterile Compounding.

Muhannad Dirbas1, Aseel K AbuSara1, Shatha Whiyabi1

  • 1Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.

International Journal of Pharmaceutical Compounding
|November 20, 2020
PubMed
Summary

A structured sterile compounding training program was developed and implemented in a Jordanian cancer center. The program successfully improved competency and trainee satisfaction, highlighting the need for future time optimization studies.

More Related Videos

Automation of a Positron-emission Tomography PET Radiotracer Synthesis Protocol for Clinical Production
10:20

Automation of a Positron-emission Tomography PET Radiotracer Synthesis Protocol for Clinical Production

Published on: October 26, 2018

11.6K
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.2K

Related Experiment Videos

Last Updated: Nov 29, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.1K
Automation of a Positron-emission Tomography PET Radiotracer Synthesis Protocol for Clinical Production
10:20

Automation of a Positron-emission Tomography PET Radiotracer Synthesis Protocol for Clinical Production

Published on: October 26, 2018

11.6K
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.2K

Area of Science:

  • Pharmacy practice
  • Oncology pharmacy
  • Medication safety

Background:

  • A gap analysis revealed non-compliance with international sterile compounding standards in Jordan.
  • A need for structured training was identified to enhance pharmaceutical practices.

Purpose of the Study:

  • To describe the development and implementation of a sterile compounding training program.
  • To assess trainee competency and satisfaction in a comprehensive cancer center.

Main Methods:

  • A structured training program with theoretical and practical components was designed.
  • Compounding competency assessments and satisfaction questionnaires were administered.
  • The program was implemented over one year, enrolling pharmacists and technicians.

Main Results:

  • 25 pharmacists and 7 technicians completed the program.
  • 100% trainee satisfaction with training objectives and instructors.
  • Minor suggestions for increased time for individual practice and discussion were noted.

Conclusions:

  • A pharmaceutical sterile compounding training program was successfully implemented.
  • The program demonstrated documented trainee competency and high satisfaction.
  • Further evaluation of optimal program duration is recommended.